AlphaGalileo is a service for the media.
Journalists should register for free access to embargoed
news and press office contact information.
Please register view details
Please register to view contact details
Please log in or register to view articles older than 3 months
This item is under embargo and is only visible to journalists
Bookmark this item in My Area
This item is bookmarked
Add comments to this news release
In a Journal of the American Geriatrics Society study, a blood-based precision medicine test incorporating age, sex, and gene expression score (ASGES) was helpful in evaluating older outpatients with symptoms suggestive of obstructive coronary artery disease (CAD).In the study of 176 stable, non-acute outpatients presenting with symptoms suggestive of obstructive CAD who were aged 65 and older, participants with low scores with low likelihood of obstructive CAD were referred for further evaluation at low rates, whereas those with higher scores had higher rates of referral to cardiology and advanced cardiovascular tests. At 1-year follow-up, the incidence of major adverse cardiovascular events or revascularization was higher in participants with high ASGES than in those with low ASGES (10 percent versus 0 percent).Access the Paper:
Joseph A. Ladapo, MD, PhD, Matthew J. Budoff, MD, David Sharp, DO, Jane Z. Kuo, MD, PhD, Lin Huang, PhD, Bruce Maniet, DO, Lee Herman, MD and Mark Monane, MD, MS. Utility of a Precision Medicine Test in Elderly Adults with Symptoms Suggestive of Coronary Artery Disease. Journal of the American Geriatrics Society. DOI: 10.1111/jgs.15215.
This item has been withdrawn. Registered users can contact the publishing organisation for further details by logging in